Skip to main content

Bioventus Inc.

BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001665988

No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $509.4M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Bioventus Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of BVS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders9894−4
Shares34.0M35.1M+1.09M (+3.2%)
Value$232.0M$245.9M+$13.9M (+6.0%)

New holders (11)

Institutions that held Bioventus Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to BVS in Q3 2022
InstitutionSharesValue% of portfolio
Nantahala Capital Management, LLC378,839$2.65M0.26%
Susquehanna Fundamental Investments, LLC32,917$230.0K0.00%
State of Wisconsin Investment Board29,516$207.0K0.00%
CWM, LLC19,230$135.0K0.00%
Mirae Asset Global Investments Co., Ltd.13,452$94.0K0.00%
Almanack Investment Partners, LLC.1,517$11.0K0.00%
China Universal Asset Management Co., Ltd.577$4.00K0.00%
Geneos Wealth Management Inc.500$3.00K0.00%
Covestor Ltd484$3.00K0.00%
US Bancorp154$1.00K0.00%
Rockefeller Capital Management L.P.163$1.00K0.00%

Sold out (15)

Institutions that held Bioventus Inc. at the end of Q2 2022 and filed for Q3 2022 without it.